| 1. Romero L, Zamanillo D, Nadal X, Sánchez-Arroyos R, Rivera-Arconada I, Dordal A, Montero A, Muro A, Bura A, Segalés C et al.. (2012) Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization.. Br J Pharmacol, 166 (8): (2289-306). [PMID:22404321] |
| 2. Díaz JL, Cuberes R, Berrocal J, Contijoch M, Christmann U, Fernández A, Port A, Holenz J, Buschmann H, Laggner C et al.. (2012) Synthesis and biological evaluation of the 1-arylpyrazole class of σ(1) receptor antagonists: identification of 4-{2-[5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yloxy]ethyl}morpholine (S1RA, E-52862).. J Med Chem, 55 (19): (8211-24). [PMID:22784008] |
| 3. Wünsch B. (2012) The σ(1) receptor antagonist S1RA is a promising candidate for the treatment of neurogenic pain.. J Med Chem, 55 (19): (8209-10). [PMID:22951043] |
| 4. Nieto FR, Cendán CM, Sánchez-Fernández C, Cobos EJ, Entrena JM, Tejada MA, Zamanillo D, Vela JM, Baeyens JM. (2012) Role of sigma-1 receptors in paclitaxel-induced neuropathic pain in mice.. J Pain, 13 (11): (1107-21). [PMID:23063344] |
| 5. Vidal-Torres A, de la Puente B, Rocasalbas M, Touriño C, Bura SA, Fernández-Pastor B, Romero L, Codony X, Zamanillo D, Buschmann H et al.. (2013) Sigma-1 receptor antagonism as opioid adjuvant strategy: enhancement of opioid antinociception without increasing adverse effects.. Eur J Pharmacol, 711 (1-3): (63-72). [PMID:23632394] |
| 6. Sánchez-Fernández C, Montilla-García Á, González-Cano R, Nieto FR, Romero L, Artacho-Cordón A, Montes R, Fernández-Pastor B, Merlos M, Baeyens JM et al.. (2014) Modulation of peripheral μ-opioid analgesia by σ1 receptors.. J Pharmacol Exp Ther, 348 (1): (32-45). [PMID:24155346] |
| 7. Gris G, Merlos M, Vela JM, Zamanillo D, Portillo-Salido E. (2014) S1RA, a selective sigma-1 receptor antagonist, inhibits inflammatory pain in the carrageenan and complete Freund's adjuvant models in mice.. Behav Pharmacol, 25 (3): (226-35). [PMID:24776490] |
| 8. Merlos M, Burgueño J, Portillo-Salido E, Plata-Salamán CR, Vela JM. (2017) Pharmacological Modulation of the Sigma 1 Receptor and the Treatment of Pain.. Adv Exp Med Biol, 964 (3): (85-107). [PMID:28315267] |
| 9. Täubel J, Ferber G, Lorch U, Wang D, Sust M, Camm AJ. (2015) Single Doses up to 800 mg of E-52862 Do Not Prolong the QTc Interval--A Retrospective Validation by Pharmacokinetic-Pharmacodynamic Modelling of Electrocardiography Data Utilising the Effects of a Meal on QTc to Demonstrate ECG Assay Sensitivity.. PLoS ONE, 10 (8): (e0136369). [PMID:26291080] |
| 10. Tejada MA, Montilla-García A, Cronin SJ, Cikes D, Sánchez-Fernández C, González-Cano R, Ruiz-Cantero MC, Penninger JM, Vela JM, Baeyens JM et al.. (2017) Sigma-1 receptors control immune-driven peripheral opioid analgesia during inflammation in mice.. Proc Natl Acad Sci USA, 114 (31): (8396-8401). [PMID:28716934] |
| 11. Bruna J, Videla S, Argyriou AA, Velasco R, Villoria J, Santos C, Nadal C, Cavaletti G, Alberti P, Briani C et al.. (2018) Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial.. Neurotherapeutics, 15 (1): (178-189). [PMID:28924870] |
| 12. Dorsey SG. (2018) Selective Blockade of the Sigma 1 Receptor Has Beneficial Effects on Both Acute and Chronic Oxaliplatin-Induced Peripheral Neuropathy.. Neurotherapeutics, 15 (1): (176-177). [PMID:29110212] |
| 13. Bruna J, Velasco R. (2018) Sigma-1 receptor: a new player in neuroprotection against chemotherapy-induced peripheral neuropathy.. Neural Regen Res, 13 (5): (775-778). [PMID:29862996] |
| 14. Castany S, Codony X, Zamanillo D, Merlos M, Verdú E, Boadas-Vaello P. (2019) Repeated Sigma-1 Receptor Antagonist MR309 Administration Modulates Central Neuropathic Pain Development After Spinal Cord Injury in Mice.. Front Pharmacol, 10 (3): (222). [PMID:30967775] |
| 15. Vidal-Torres A, Fernández-Pastor B, Carceller A, Vela JM, Merlos M, Zamanillo D. (2019) Supraspinal and Peripheral, but Not Intrathecal, σ1R Blockade by S1RA Enhances Morphine Antinociception.. Front Pharmacol, 10 (3): (422). [PMID:31068818] |
| 16. Carcolé M, Zamanillo D, Merlos M, Fernández-Pastor B, Cabañero D, Maldonado R. (2019) Blockade of the Sigma-1 Receptor Relieves Cognitive and Emotional Impairments Associated to Chronic Osteoarthritis Pain.. Front Pharmacol, 10 (3): (468). [PMID:31130863] |
C2306179